National Bank Financial downgraded shares of SNC-Lavalin Group (TSE:ATR – Free Report) from a strong-buy rating to a hold rating in a research note published on Wednesday morning,Zacks.com reports. National Bank Financial also issued estimates for SNC-Lavalin Group’s Q2 2025 earnings at $0.71 EPS, Q3 2025 earnings at $0.85 EPS, Q4 2025 earnings at $0.82 EPS, FY2025 earnings at $3.01 EPS and FY2026 earnings at $3.83 EPS.
SNC-Lavalin Group Price Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Articles
- Five stocks we like better than SNC-Lavalin Group
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- Top Stocks Investing in 5G Technology
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- A Deeper Look at Bid-Ask Spreads
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
